Who Should Choose Tirzepatide: Ideal Candidates: Need maximum weight loss (50+ pounds) Want most effective medication available Can afford $349-$1,069/month depending on option Have BMI 30 (or 27 with comorbidities) Plateaued on semaglutide or other medications No contraindications to GLP-1/GIP agonists Particularly Good For: Significant obesity (BMI 35) Previous weight loss medication failures Those who want best possible results Patients who tolerate GLP-1s well Cost Comparison: Value Analysis: Cost per % Body Weight Lost: Brand-Name Tirzepatide: 22.5% loss at $12,828/year Cost per %: $570 Compounded Tirzepatide (TrimRx): 22.5% loss at $4,188/year Cost per %: $186 Compounded Semaglutide (TrimRx): 14.9% loss at $2,388/year Cost per %: $160 Both compounded options offer excellent value, with semaglutide being slightly more cost-efficient per percentage lost, while tirzepatide produces greater absolute weight loss
IGF-1 LR3 also has a significantly longer half-life than IGF-1
2.3.2 Chronic inflammation and telomers Over the past decade, the complex interplay between telomere dynamics and chronic inflammation has gained further attention
A.SeeleyR
(2019) demonstrated significant antidepressant activity of AC in a study evaluating its effects in stressed mice
Furthermore, recent evidence has indicated that some of the inflammation produced by intrarectal administration of TNBS may be mediated by a burst of ROS produced from its metabolism within the mucosal interstitium (Grisham et al, 1991)
